Nirvana Life Sciences Inc. (CSE:NIRV)
0.1400
 +0.1100 (366.67%)
  Oct 10, 2025, 5:23 PM EDT
366.67% (1Y)
| Market Cap | 3.20M | 
| Revenue (ttm) | n/a | 
| Net Income (ttm) | -346.30K | 
| Shares Out | 22.82M | 
| EPS (ttm) | -0.04 | 
| PE Ratio | n/a | 
| Forward PE | n/a | 
| Dividend | n/a | 
| Ex-Dividend Date | n/a | 
| Volume | 1,000 | 
| Average Volume | 50 | 
| Open | 0.1400 | 
| Previous Close | 0.0300 | 
| Day's Range | 0.1400 - 0.1400 | 
| 52-Week Range | 0.0300 - 0.7500 | 
| Beta | 0.22 | 
| RSI | 83.63 | 
| Earnings Date | Dec 9, 2025 |